247 related articles for article (PubMed ID: 22999555)
21. Microdose flare protocol with interrupted follicle stimulating hormone and added androgen for poor responders--an observational pilot study.
Mitri F; Behan LA; Murphy CA; Hershko-Klement A; Casper RF; Bentov Y
Fertil Steril; 2016 Jan; 105(1):100-5.e1-6. PubMed ID: 26496380
[TBL] [Abstract][Full Text] [Related]
22. Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis.
Datta AK; Maheshwari A; Felix N; Campbell S; Nargund G
Hum Reprod Update; 2021 Feb; 27(2):229-253. PubMed ID: 33146690
[TBL] [Abstract][Full Text] [Related]
23. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
24. Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial.
Fábregues F; Peñarrubia J; Creus M; Manau D; Casals G; Carmona F; Balasch J
Hum Reprod; 2009 Feb; 24(2):349-59. PubMed ID: 19054777
[TBL] [Abstract][Full Text] [Related]
25. Androgens and diminished ovarian reserve: the long road from basic science to clinical implementation. A comprehensive and systematic review with meta-analysis.
Neves AR; Montoya-Botero P; Polyzos NP
Am J Obstet Gynecol; 2022 Sep; 227(3):401-413.e18. PubMed ID: 35364061
[TBL] [Abstract][Full Text] [Related]
26. The effectiveness of transdermal testosterone gel 1% (androgel) for poor responders undergoing in vitro fertilization.
Doan HT; Quan LH; Nguyen TT
Gynecol Endocrinol; 2017 Dec; 33(12):977-979. PubMed ID: 28562099
[TBL] [Abstract][Full Text] [Related]
27. WITHDRAWN: Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
Daya S; Gunby J
Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD002810. PubMed ID: 17636708
[TBL] [Abstract][Full Text] [Related]
28. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
Daya S; Gunby J
Cochrane Database Syst Rev; 2000; (4):CD002810. PubMed ID: 11034767
[TBL] [Abstract][Full Text] [Related]
29. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
30. A retrospective evaluation of prognosis and cost-effectiveness of IVF in poor responders according to the Bologna criteria.
Busnelli A; Papaleo E; Del Prato D; La Vecchia I; Iachini E; Paffoni A; Candiani M; Somigliana E
Hum Reprod; 2015 Feb; 30(2):315-22. PubMed ID: 25432927
[TBL] [Abstract][Full Text] [Related]
31. Effect of pretreatment with transdermal testosterone on poor ovarian responders undergoing IVF/ICSI: A meta-analysis.
Luo S; Li S; Li X; Qin L; Jin S
Exp Ther Med; 2014 Jul; 8(1):187-194. PubMed ID: 24944620
[TBL] [Abstract][Full Text] [Related]
32. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
[TBL] [Abstract][Full Text] [Related]
33. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].
Wu CX; Zhang T; Shu L; Huang J; Diao FY; Ding W; Gao Y; Wang W; Mao YD; Cui YG; Liu JY
Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):160-166. PubMed ID: 29609229
[No Abstract] [Full Text] [Related]
34. Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study.
Vlahos N; Papalouka M; Triantafyllidou O; Vlachos A; Vakas P; Grimbizis G; Creatsas G; Zikopoulos K
Reprod Biomed Online; 2015 Feb; 30(2):191-6. PubMed ID: 25498594
[TBL] [Abstract][Full Text] [Related]
35. Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis.
Sunkara SK; Pundir J; Khalaf Y
Reprod Biomed Online; 2011 Jun; 22(6):545-55. PubMed ID: 21493151
[TBL] [Abstract][Full Text] [Related]
36. Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome.
Wei D; Shi Y; Li J; Wang Z; Zhang L; Sun Y; Zhou H; Xu Y; Wu C; Liu L; Wu Q; Zhuang L; Du Y; Li W; Zhang H; Legro RS; Chen ZJ
Hum Reprod; 2017 Feb; 32(2):354-361. PubMed ID: 27999118
[TBL] [Abstract][Full Text] [Related]
37. Predictive value of androgens and multivariate model for poor ovarian response.
Guo J; Zhang Q; Li Y; Huang J; Wang W; Huang L; Zhao X; Yang D
Reprod Biomed Online; 2014 Jun; 28(6):723-32. PubMed ID: 24745840
[TBL] [Abstract][Full Text] [Related]
38. Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization.
Boostanfar R; Shapiro B; Levy M; Rosenwaks Z; Witjes H; Stegmann BJ; Elbers J; Gordon K; Mannaerts B;
Fertil Steril; 2015 Jul; 104(1):94-103.e1. PubMed ID: 26003273
[TBL] [Abstract][Full Text] [Related]
39. Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI.
Polyzos NP; Nwoye M; Corona R; Blockeel C; Stoop D; Haentjens P; Camus M; Tournaye H
Reprod Biomed Online; 2014 Apr; 28(4):469-74. PubMed ID: 24581984
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): A proof of principle double blinded randomized placebo controlled trial.
Narkwichean A; Maalouf W; Baumgarten M; Polanski L; Raine-Fenning N; Campbell B; Jayaprakasan K
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():39-48. PubMed ID: 28934714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
